Medical Adhesive Repeat Application Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

56 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-08

Study Completion Date

2021-05-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to determine the relative effects imparted by different medical tapes to skin when comparing normal skin to skin after ten repeated tape applications and removals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device)

NCT04836572

Healthy Volunteer Study

COMPLETED NA

Study to Assess Adhesion Quality and Wear of Placebo JNJ-35685-AAA-G-023 Transdermal System in Healthy Adults

NCT02221726

Healthy

COMPLETED EARLY_PHASE1

Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing

NCT02570139

Incontinence Associated Dermatitis

TERMINATED NA

Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol

NCT03125824

Tattooing

COMPLETED NA

LEAFix Adhesion in Healthy Volunteers

NCT05415059

Adhesion

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is to evaluate changes to skin after repeated tape stripping on volar forearm with various medical tapes. Assessments of effects to skin include corneocytes, total protein (BCA), Trans-Epidermal Water Loss (TEWL), and cytokine analysis.

The Study will involve the application of eight (8) test articles. In each case, the test articles will be applied to eight (8) sites on the healthy Subject's left and right volar forearms (four \[4\] sites on the left, and four \[4\] sites on the right) in a randomized fashion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects with tape samples

each subject had 8 types of tape samples applied on their arms

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male and female ages 18-65 years.
2. Has sufficient area to fit five (5)1 inch by 2.5-inch sites on each volar forearm.
3. Agrees to have five (5) 1 inch by 2.5-inch test sites marked on each volar forearm with a non-toxic permanent marker (Sharpie).
4. Agrees to stop the use of all topical products (lotions, creams, oils, sunscreen, bug spray, etc.) on their volar forearms 3 days prior to the start of the study.
5. Agrees to not shower within 24 hours of their D1 visit.
6. Agrees to not wash volar forearms when washing hands within 24 hours of their D1 visit.
7. Agrees to refrain from exercising or drinking hot beverages or cold/iced coffee or tea (caffeinated or energy drinks) during the 2 hours prior to their D1 visit.
8. Agrees that if the study personnel feel that they have excessive hair on their volar forearm test sites that the hair may be clipped at the D1 visit.
9. Agrees to wear or be willing to change into a short-sleeved shirt or a shirt with sleeves that can be pulled or rolled above the elbows to each visit.
10. Able to read, understand, and sign the Informed Consent Form (ICF).
11. Willing and able to follow all study requirements and restrictions

Exclusion Criteria

1. If female, is pregnant, nursing, or planning a pregnancy during the study as determined by interview.
2. If female, is currently experiencing hot flashes (this affects the measurements) or has increased localized or generalized sweating (hyperhidrosis).
3. Is a smoker.
4. Has a history of lightening or darkening of the skin due to tape application and removal.
5. Has diabetes Type 1 or Type 2.
6. Has a current skin condition on the volar forearms (e.g., psoriasis, eczema, atopic dermatitis, etc., or active cancer) that the Investigator or designee deems inappropriate for participation or could interfere with the outcome of the study.
7. Is currently taking, or in the past 2 weeks has taken any anti-inflammatory drug (e.g., aspirin, ibuprofen, Celebrex \[COX-2 inhibitor\], corticosteroids), immunosuppressive drugs, or antihistamine medications.
8. Is currently applying, or in the past 2 weeks has applied topical drugs to the volar forearm test sites.
9. Has any medical condition that, in the Investigator's judgment, makes the Subject ineligible or places the Subject at undue risk.
10. Is currently participating in any clinical testing, including other studies being conducted at Dermico LLC.
11. Has damaged skin in or around the test sites, which includes sunburn, extremely deep tans, uneven skin tones, tattoos, scars, excessive hair that they are not willing to have clipped, numerous freckles, blemishes, or other disfiguration of the test sites.
12. Has a confirmed allergy or sensitivity to adhesives.
13. Has a history of a confirmed or suspected COVID-19 infection within 30 days prior to the study visit.
14. Has had contact with a COVID-19-infected person or persons within 14 days prior to the study visit.
15. Individual or a member of the individual's household has traveled internationally within 14 days prior to the study visit.
16. Has experienced any of the following self-reported symptoms of COVID-19 within 2 weeks prior to the study visit:

* Unexplained cough, shortness of breath/difficulty breathing, fatigue, body aches (headaches, muscle pain, stomachaches), conjunctivitis, loss of smell, loss of taste, poor appetite, nausea, vomiting, diarrhea, palpitations, or chest pain/tightness.
* Temperature ≥ 100. 4o F, measured

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes